All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Cellprotect Nordic Pharmaceuticals AB, of Stockholm, said its cell therapy candidate, Cellprotect, has received EMA orphan drug status for the treatment of multiple myeloma.
